Norris Financial Group’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-14,917	Closed	-$265K	–	87
2024 Q2	$265K	Sell	14,917 -467	-3%	-$7.45K	0.14%	66
2024 Q1	$234K	Sell	15,384 -1,033	-6%	-$16.5K	0.13%	68
2023 Q4	$280K	Buy	16,417 +4,263	+35%	+$49.5K	0.17%	55
2023 Q3	$102K	Buy	+12,154	New	+$169K	0.07%	61
2023 Q2	–	Sell	-26,913	Closed	-$405K	–	73
2023 Q1	$405K	Sell	26,913 -6,591	-20%	-$100K	0.3%	49
2022 Q4	$396K	Buy	33,504 +1,602	+5%	+$11.6K	0.34%	50
2022 Q3	$189K	Buy	31,902 +3,845	+14%	+$25.2K	0.17%	62
2022 Q2	$119K	Buy	28,057 +3,328	+13%	+$20.8K	0.1%	62
2022 Q1	$235K	Buy	24,729 +9,309	+60%	+$108K	0.14%	69
2021 Q4	$293K	Buy	15,420 +6,586	+75%	+$171K	0.18%	68
2021 Q3	$294K	Buy	+8,834	New	+$273K	0.19%	67
2021 Q2	–	Sell	-4,580	Closed	-$221K	–	89
2021 Q1	$221K	Buy	+4,580	New	+$220K	0.16%	71